The recent publication of the results of this study indicated that although APRIL protein had reasonable binding affinity for BCMA that was comparable to a single-chain variable fragment, APRIL-based CARs induced poor T cell activation, weak cytokine production, and had reduced binding avidity to tumor cells. The gene discussed is TNFRSF17; the disease is neoplasm.